Dr. Reddy'S Labs Launches Generic Syprine Capsules In Us Market
Dr. Reddy'S Laboratories Ltd Announced The Launch Of The Us Food And Drug Administration (Fda) Approved Trientine Hydrochloride Capsules Usp, 250 Mg, A Therapeutically Equivalent Generic Version Of Syprine (Trientine Hydrochloride) Capsules.Dr Reddy'S Trientine Hydrochloride Capsules Usp, 250 Mg Are Available In 100 Count Bottles."We Are Pleased To Provide This Convenient Alternative For Patients, Pharmacists And Distribution Partners," Explains Marc Kikuchi, Chief Executive Officer And Head Of Dr. Reddy'S North America Generics. "Our Product Can Be Stored At Room Temperature (20°C To 25°C Or 68° F To 77°F) Throughout The Product Shelf Life Of 24 Months."The Syprine Brand And Generic Products Had Us Sales Or Approximately Us$ 94.2 Million Mat For The Most Recent Twelve Months Ending In December 2019, According Toiqvia.
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!